CTLA4 and melanoma: SRS, stereotactic radiosurgery; HR, Hazard ratio; NS; not significant; NR, not reported; MBM, melanoma brain metastases; PD-1, programmed cell death protein 1; CTLA4, cytotoxic T-lymphocyte-associated protein 4; IMT, immunotherapy